FY2023 NIH awards · Principal investigators
Internal Medicine at UT MD Anderson Cancer Center
Houston, TX
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Internal Medicine row of the UT MD Anderson Cancer Center page.
Leads a grant in this department
103 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Richie, Ellen R
Leads 1 award · $2,800,314
- 5P01AI139449-04Department: NIH department codeMechanisms controlling distinct growth and functional characteristics of the perinatal and adult thymus$2,800,314award amount
Davies, Michael
Leads 2 awards · $2,673,069
- 5P50CA221703-05Department: NIH department codeThe University of Texas MD Anderson Cancer Center SPORE in Melanoma$2,070,386award amount
- 5T32CA009666-29Department: NIH department codeResearch Training in Academic Medical Oncology$602,683award amount
Kopetz, Scott
Leads 1 award · $2,203,749
- 5P50CA221707-05Department: NIH department codeMD Anderson Cancer Center SPORE in Gastrointestinal Cancer$2,203,749award amount
Bast, Robert C
Leads 1 award · $2,144,148
- 1P50CA281701-01Department: NIH department codeThe University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer$2,144,148award amount
Capasso, Anna
Leads 1 award · $1,952,013
- 4UM1CA186688-07Department: NIH department codeTexas EXperimental Cancer Therapeutics Network - TEX CTN$1,952,013award amount
Green, Michael Richard
Leads 3 awards · $1,463,511
- 5R01CA266279-02Department: NIH department codeBAF complex deregulation in lymphoma$672,389award amount
- 5R01CA240839-03Department: NIH department codeFunctional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma$432,113award amount
- 5R01CA201380-07Department: NIH department codeIdentifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$359,009award amount
Morelli, Maria Pia
Leads 1 award · $1,406,916
- 1UG3CA283615-01Department: NIH department codeHORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer$1,406,916award amount
Vilar Sanchez, Eduardo
Leads 1 award · $1,363,358
- 5UG1CA242609-05Department: NIH department codeiCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium$1,363,358award amount
Fahrmann, Johannes F
Leads 2 awards · $1,150,115
- 1U01CA282216-01Department: NIH department codeBlood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer$672,298award amount
- 1R37CA269611-01A1Department: NIH department codeRepurposing Glucosylceramide Synthase to Promote Mitochondrial Lethality and Potentiate an Anti-Tumor Immune Response in Triple-Negative Breast Cancer$477,817award amount
Afshar-Kharghan, Vahid
Leads 2 awards · $1,113,506
- 1R01CA275762-01A1Department: NIH department codeNovel Biomarkers Predicting Blood Clots in Ovarian Cancer$634,124award amount
- 5R01CA177909-10Department: NIH department codePlatelets promote growth of ovarian cancer$479,382award amount
Heymach, John V.
Leads 2 awards · $1,112,869
- 5R01CA247975-04Department: NIH department codeMolecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors$566,537award amount
- 5R01CA234183-04Department: NIH department codeTherapeutic strategies against EGFR exon 20 mutant lung cancer$546,332award amount
Skoulidis, Ferdinandos
Leads 3 awards · $1,104,314
- 1R01CA272570-01A1Department: NIH department codeDissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancer$370,575award amount
- 1R01CA279194-01Department: NIH department codeDissecting and targeting tumor-TME crosstalk to forestall acquired KRASG12C inhibitor resistance in NSCLC.$370,575award amount
- 5R01CA262469-03Department: NIH department codeUnderstanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer$363,164award amount
Giordano, Sharon Hermes
Leads 1 award · $1,091,199
- 5U54CA096300-20Department: NIH department codeUPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,091,199award amount
Hunt, Kelly K
Leads 1 award · $1,045,256
- 5UG1CA233329-05Department: NIH department codeUT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1$1,045,256award amount
Hanash, Samir M
Leads 1 award · $1,023,059
- 5U01CA271888-02Department: NIH department codeClinical Validation Center for Lung Cancer Early Detection$1,023,059award amount
Bresalier, Robert S
Leads 1 award · $1,016,923
- 5U01CA086400-22Department: NIH department codeGreat Lakes New England Clinical Validation Center$1,016,923award amount
Bast, Robert C
Leads 1 award · $1,014,275
- 2U01CA200462-06A1Department: NIH department codeMD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm$1,014,275award amount
Chen Yu
Leads 1 award · $1,005,497
- 5U01CA224044-05Department: NIH department codePatient-Derived Models of Prostate Cancer for Personalized Medicine$1,005,497award amount
Kurie, Jonathan M
Leads 2 awards · $995,515
- 5R01CA251067-03Department: NIH department codeElucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2$527,923award amount
- 5R01CA255021-03Department: NIH department codeA pro-metastatic secretory pathway activated by p53 loss in lung cancer$467,592award amount
Bhalla, Kapil
Leads 2 awards · $953,316
- 5R01CA255721-03Department: NIH department codeBiology and novel therapy of AML expressing somatic or germline mutant RUNX1$486,972award amount
- 5R01CA233457-04Department: NIH department codeTargeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAML$466,344award amount
Byers, Lauren Averett
Leads 2 awards · $941,460
- 5U01CA256780-03Department: NIH department codeMolecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response$561,956award amount
- 5R01CA207295-07Department: NIH department codeDNA damaging therapy and immune response in small cell lung cancer subtypes$379,504award amount
Shpall, Elizabeth J
Leads 1 award · $918,606
- 3P50CA100632-20S1Department: NIH department codeSPORE University of Texas M. D. Anderson Cancer Center-Leukemia$918,606award amount
Evans, Scott E.
Leads 1 award · $880,000
- 5R35HL144805-05Department: NIH department codeInducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia$880,000award amount
Danesh, Farhad R
Leads 2 awards · $815,239
- 5R01DK091310-14Department: NIH department codeMicroRNA In Diabetic Nephropathy$458,839award amount
- 5R01DK078900-15Department: NIH department codeRole of Rho Kinase in Diabetic Nephropathy$356,400award amount
Rai, Kunal
Leads 2 awards · $766,394
- 5R01CA245395-04Department: NIH department codeUCHL5 as a regulator and therapeutic target in metastatic melanoma$403,230award amount
- 5R01CA226269-04Department: NIH department codeRole of UBR7, a novel H2BK120 E3 ubiquitin ligase, in suppression of breast cancer$363,164award amount
Genovese, Giannicola
Leads 2 awards · $737,606
- 5R01CA258226-03Department: NIH department codeInvestigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma$552,054award amount
- 5R21CA259799-02Department: NIH department codeClonal drivers of resistance to immune checkpoint blockade in liver malignancies$185,552award amount
Vokes, Natalie
Leads 1 award · $676,561
- 1R01CA276178-01A1Department: NIH department codeIntegrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer$676,561award amount
Cohen, Lorenzo
Leads 1 award · $669,504
- 1R01CA272565-01A1Department: NIH department codeOpioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery$669,504award amount
Hong, David S.
Leads 1 award · $663,405
- 5K12CA088084-22Department: NIH department codePaul Calabresi Clinical Oncology Award$663,405award amount
Lipkin, Steven M
Leads 1 award · $660,089
- 5R01CA257375-03Department: NIH department codeCancer Immune-Interception for Lynch Syndrome$660,089award amount
Johnson, Faye
Leads 1 award · $657,573
- 5R01CA269516-02Department: NIH department codeTargeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor$657,573award amount
Reyes-Gibby, Cielito C
Leads 1 award · $648,983
- 5R01CA267856-02Department: NIH department codeImproving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)$648,983award amount
Frigo, Daniel Edward
Leads 2 awards · $647,182
- 1R01CA275138-01A1Department: NIH department codeRevisiting Antiangiogenic Therapy to Target Hormone-Sensitive Prostate Cancer Metabolism$566,917award amount
- 5R03CA270450-02Department: NIH department codeDelineation of the Role of CAMKK2 in Bone-metastatic Prostate Cancer and its Therapeutic Implications$80,265award amount
Frederick, Mitchell J.
Leads 1 award · $637,606
- 5R01CA235620-05Department: NIH department codeTargeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)$637,606award amount
Gray, Stanton Bradley
Leads 1 award · $637,581
- 5R01CA260761-02Department: NIH department codeCancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome$637,581award amount
Aparicio, Ana
Leads 1 award · $636,578
- 1R01CA283402-01Department: NIH department codeEffects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)$636,578award amount
Mazur, Pawel K.
Leads 1 award · $629,409
- 5R01CA266280-02Department: NIH department codeTumor cell lineage diversity and composition in gastric cancer progression and therapy resistance$629,409award amount
Amin, Hesham M
Leads 1 award · $608,666
- 5R01CA260872-03Department: NIH department codeA Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients$608,666award amount
Chen, Jichao
Leads 1 award · $608,155
- 5R01HL130129-08Department: NIH department codeRegulation of mesenchymal cells by epithelial Wnt ligands$608,155award amount
Ma, Jingfei
Leads 1 award · $600,309
- 5R01CA231513-05Department: NIH department codeDevelopment and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications$600,309award amount
Andreeff, Michael
Leads 2 awards · $596,334
- 5R01FD006118-03Department: NIH department codePh1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)$373,673award amount
- 5R21CA267401-02Department: NIH department codeTherapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML$222,661award amount
Li, Chun
Leads 1 award · $569,704
- 5R01CA258540-02Department: NIH department codeDevelopment of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma$569,704award amount
Puduvalli, Vinay K
Leads 1 award · $568,351
- 5R01CA235673-05Department: NIH department codeA Novel Hsp90 Inhibitor as a Chemo and Radiosensitizer in Adults with Glioblastoma$568,351award amount
Neelapu, Sattva S
Leads 1 award · $561,726
- 5R01CA273130-02Department: NIH department code[18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events$561,726award amount
Dickey, Burton F
Leads 1 award · $537,168
- 5R01HL129795-08Department: NIH department codeControlling the core airway mucin secretion machinery to prevent pathophysiology$537,168award amount
Bhalla, Kapil
Leads 1 award · $523,503
- 5R01CA262636-03Department: NIH department codeNovel combination therapy for AML expressing mutant RUNX1$523,503award amount
Yennu, Sriram
Leads 1 award · $498,007
- 5R01CA231521-05Department: NIH department codeA Combination Therapy to Treat Cancer-Related Fatigue$498,007award amount
Abe, Jun-Ichi
Leads 1 award · $495,268
- 5U01AI156921-04Department: NIH department codeMitigating radiation-induced cardiovascular disease by inhibiting premature aging$495,268award amount
Cole, Francesca
Leads 3 awards · $484,277
- 5R01HD098129-05Department: NIH department codeHow age-dependent alterations in meiotic recombination cause chromosome mis-segregation in sperm$386,379award amount
- 3R01HD098129-05S1Department: NIH department codeHow age-dependent alterations in meiotic recombination cause chromosome mis-segregation in sperm$83,136award amount
- 3R01HD098129-04S1Department: NIH department codeHow age-dependent alterations in meiotic recombination cause chromosome mis-segregation in sperm$14,762award amount
Iqbal, Javeed
Leads 1 award · $474,235
- 5R01CA266612-02Department: NIH department codeRole of Heat Shock Protein 70 as a Mediator and Therapeutic Target in T-cell Lymphomas$474,235award amount
Goswami, Sangeeta
Leads 1 award · $469,956
- 1R37CA279192-01Department: NIH department codeTargeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM$469,956award amount
Bartholomew, Blaine
Leads 1 award · $455,220
- 5R01GM108908-08Department: NIH department codeRegulation of chromatin organization and dynamics by INO80$455,220award amount
Viale, Andrea
Leads 1 award · $450,830
- 5R01CA258917-03Department: NIH department codeMitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer$450,830award amount
Green, Michael Richard
Leads 1 award · $444,385
- 5R01CA247883-03Department: NIH department codeRoles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis$444,385award amount
Hui, David
Leads 1 award · $441,646
- 5R01CA231471-04Department: NIH department codeEfficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients$441,646award amount
Yao, Wantong
Leads 1 award · $434,594
- 5R37CA272744-02Department: NIH department codeTargeting Acquired Resistance in KRAS Driven Cancers$434,594award amount
Sahni, Nidhi
Leads 1 award · $405,000
- 5R35GM137836-04Department: NIH department codeDeciphering Functional Consequences of Specific and Combinatorial Mutations in Protein Interaction Networks$405,000award amount
Xu, Han
Leads 1 award · $405,000
- 5R35GM137927-04Department: NIH department codeComputational approaches for protein functional analysis using CRISPR screens$405,000award amount
Dent, Sharon Y. R.
Leads 1 award · $400,000
- 5R35GM131678-05Department: NIH department codeGenetic and Molecular Definition of Histone Modifying Enzyme Functions$400,000award amount
Dantzer, Robert
Leads 1 award · $399,810
- 5R01CA193522-09Department: NIH department codeThe Metabolic Basis of Cancer-Related Fatigue$399,810award amount
Ting, Angela H
Leads 1 award · $392,412
- 7R01CA230033-05Department: NIH department codeUnderstanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end$392,412award amount
Lin, Shiaw-Yih
Leads 1 award · $376,433
- 5R01CA251206-03Department: NIH department codeRNase H2 is a novel therapeutic target in triple negative breast cancer$376,433award amount
Wu, Xiangwei
Leads 1 award · $375,065
- 5R01CA214954-06Department: NIH department codeActivating p53 for colorectal cancer prevention$375,065award amount
Wang, Guocan
Leads 1 award · $370,575
- 1R01CA276235-01Department: NIH department codeCis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression$370,575award amount
Quarles, Christopher Chad
Leads 1 award · $369,886
- 7R01CA213158-07Department: NIH department codeEstablishing the Validity of Brain Tumor Perfusion Imaging$369,886award amount
Gibbons, Don Lynn
Leads 1 award · $363,165
- 4R37CA214609-06Department: NIH department codeThe Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer$363,165award amount
Fueyo, Juan
Leads 1 award · $363,164
- 5R01CA256006-03Department: NIH department codeGlioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$363,164award amount
Johnson, Faye
Leads 1 award · $363,164
- 5R01CA248205-04Department: NIH department codeHarnessing Aurora kinase inhibition‐induced cell death to enhance immunotherapy in HPV‐driven cancers$363,164award amount
McAllister, Florencia
Leads 1 award · $363,164
- 5R37CA237384-04Department: NIH department codeDissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis$363,164award amount
Yap, Timothy Anthony
Leads 1 award · $363,164
- 5R01CA255074-03Department: NIH department codeTranscriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors$363,164award amount
Zuo, Xiangsheng
Leads 1 award · $363,164
- 5R01CA236905-03Department: NIH department codeMolecular Understanding and Targeting of Determinant Factors in Gastric Tumorigenesis$363,164award amount
Grace, Peter M
Leads 1 award · $359,431
- 5R01CA227064-06Department: NIH department codePQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$359,431award amount
Zhang, Jianjun
Leads 1 award · $358,680
- 5R01CA234629-05Department: NIH department codeThe molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma$358,680award amount
Chari, Suresh T.
Leads 1 award · $350,540
- 5U01DK126365-04Department: NIH department codeThe Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$350,540award amount
Chen, Taiping
Leads 1 award · $348,300
- 1R01HD112473-01Department: NIH department codeRole of PRMT7 in Genomic Imprinting$348,300award amount
Maitra, Anirban
Leads 1 award · $347,918
- 5R01CA220236-06Department: NIH department codeWnt/?-catenin Signaling in Pancreatic Oncogenesis$347,918award amount
Millward, Steven W
Leads 1 award · $323,076
- 5R01CA231509-03Department: NIH department codePro-Drug Enolase Inhibitors in Precision Oncology$323,076award amount
Fan, Zhen
Leads 1 award · $294,116
- 5R01CA262288-03Department: NIH department codeDeveloping novel bispecific antibodies for cancer treatment$294,116award amount
Burks, Jared Kyle
Leads 1 award · $258,385
- 5R50CA243707-04Department: NIH department codeSingle Cell Spatial Analysis in Tissue$258,385award amount
Milbury, Kathrin
Leads 1 award · $233,186
- 5R37CA231522-06Department: NIH department codeDyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers$233,186award amount
Al-Atrash, Gheath
Leads 1 award · $227,205
- 1R21CA270491-01A1Department: NIH department codeEnhancing CAR T Cell Homing Through Glycoengineering$227,205award amount
Piwnica-Worms, David
Leads 1 award · $227,205
- 1R21CA277283-01Department: NIH department codeFirst-in-Human Imaging of Innate Immunity Activation with a Redox-Tuned PET Reporter$227,205award amount
Casarin, Stefano
Leads 1 award · $222,403
- 5R21CA267312-02Department: NIH department codeIntegrating in vivo and in silico models of prostate cancer-bone interactions to overcome anti-tumor therapy resistance$222,403award amount
Bachireddy, Pavan
Leads 1 award · $217,528
- 5K08CA248458-04Department: NIH department codeElucidating Human Leukemia and T Cell Interactions within the Tumor Microenvironment$217,528award amount
Bedford, Mark T.
Leads 1 award · $192,025
- 5R25CA181004-10Department: NIH department codeMD Anderson Science Park Summer Program in Cancer Research SPCR$192,025award amount
Lopez-Olivo, Maria De Los Angeles
Leads 1 award · $191,520
- 5K08CA237619-04Department: NIH department codeImproving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition$191,520award amount
Mulholland, Michele M
Leads 1 award · $189,785
- 5K01AG078411-02Department: NIH department codeBaboon model of chemotherapy-related cognitive impairment and accelerated aging$189,785award amount
Gandhi, Varsha
Leads 1 award · $189,338
- 1R21CA259749-01A1Department: NIH department codeA combination strategy to target pathophysiology of chronic lymphocytic leukemia$189,338award amount
Manning, Henry Charles
Leads 1 award · $189,338
- 1R21CA280238-01Department: NIH department codeQuantitative Imaging of OXPHOS in Pancreatic Cancer$189,338award amount
Abdi, Salahadin
Leads 1 award · $185,552
- 5R21CA256136-02Department: NIH department codeInnovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study$185,552award amount
Konopleva, Marina Y
Leads 1 award · $185,552
- 5R21CA259324-02Department: NIH department codeDefining the novel cancer testis antigen HSPA1L as immunotherapeutic target in AML$185,552award amount
Lin, Jamie
Leads 1 award · $165,240
- 5K08DK119466-05Department: NIH department codeThe role of ARF6 in the progression of diabetic kidney disease$165,240award amount
Ferrarotto, Renata
Leads 1 award · $162,000
- 5R03DE031333-02Department: NIH department codeExploring biomarkers of clinical benefit to VEGFR inhibitor combined with PD-L1 inhibitor in recurrent/metastatic Adenoid Cystic Carcinoma$162,000award amount
George, Goldy C
Leads 1 award · $146,757
- 5R01CA242565-04Department: NIH department codeUse of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy$146,757award amount
Batista, Marjorie
Leads 1 award · $126,629
- 5R01CA246368-04Department: NIH department codeThe interplay of the immune system, and microbiome in determining outcome of respiratory viral infections in hematopoietic cell transplant recipients and in patients with leukemia$126,629award amount
Hassan, Noha Abdelwahab Hassan Ali
Leads 1 award · $113,868
- 5K01AI163412-03Department: NIH department codeImmune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy$113,868award amount
Nilsson, Monique B
Leads 1 award · $101,401
- 5R50CA265307-03Department: NIH department codeTargeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC)$101,401award amount
Kontoyiannis, Dimitrios P
Leads 1 award · $81,000
- 5R03AI166285-02Department: NIH department codeDevelopment of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis$81,000award amount
Ayoub, Edward
Leads 1 award · $74,492
- 5F32CA271697-02Department: NIH department codeTargeting Quiescence Pathways to Overcome Chemoresistance in EVI1-Overexpressing Leukemia$74,492award amount
Enriquez, Jose S
Leads 1 award · $37,180
- 1F99CA284365-01Department: NIH department codeReal Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer$37,180award amount
Clowers, Michael Joseph
Leads 1 award · $35,191
- 5F31CA261121-02Department: NIH department codeEstrogen receptors restrict tumor-promoting inflammation in K-ras mutant lung cancer$35,191award amount
Peng, Guang
Leads 1 award · $1
- 5R01CA181663-08Department: NIH department codeMechanisms of radioresistance and strategies for radiosensitization in ovarian clear cell carcinoma$1award amount
Yee, Cassian
Leads 1 award · $1
- 5R01CA237672-05Department: NIH department codeAdoptive T Cell Therapy for Pancreatic Cancer$1award amount